Welcome to the Working Group on New TB Drugs Blog
Interview with Joel S. Freundlich
Dr. Freundlich is a Senior Research Scientist in the Biochemistry and Biophysics department at Texas A&M University and a Visiting Professor at Rutgers University in the Medicinal Chemistry department.
Interview with Stewart Cole
Stewart Cole helped create the Global Health Institute in 2007. Located at the Ecole polytechnique fédérale de Lausanne (EPFL), will use cutting-edge techniques to seek solutions to tuberculosis, a growing threat worldwide. Dr Cole’s work on tuberculosis, leprosy, AIDS, gas gangrene and bacterial molecular genetics is widely acclaimed throughout the world. He was a leading [...]
Financial Times Video Interviews on Combating TB
For World TB Day, the Financial Times’ Andrew Jack interviewed various members of the TB community to get their take on a range of topics. Interviewees are Paul Stoffels, head of R&D at Johnson & Johnson; Lucy Cheshire, a Kenyan campaigner; Paul Sommerfeld, chairman of TB Alert; Al Story, the clinical lead of a UK charity.
An Interview with Barbara Laughon of NIH/NIAID
Dr. Barbara Laughon works in the Office of the Director, Division of Microbiology and Infectious Diseases at the National Institute of Allergy & Infectious Diseases (NIH/NIAID). She is also a Core Group member of the Working Group on New TB Drugs and is the Candidates Subgroup leader. This interview was filmed at JHU on November [...]
Hans Rosling Details the Lack of TB News Coverage
Compared to the widespread news coverage during the swine flu outbreak, TB receives little coverage, especially when you calculate the ratio of news hits to mortality. During a 13 day period in April and May of 2009, the WHO confirmed 31 deaths from swine flu. In that same period, the WHO shows approximately 60,000 deaths from tuberculosis. Prof. Hans Rosling tracked news coverage of each disease using Google news search and found that swine flu was being hyped to a tremendous degree relative to the mortality figures while TB was practically being ignored.
MDR-TB patients face discrimination, long road to recovery in Peru
Video: Patients who develop multi-drug resistant tuberculosis face an arduous course of medical treatment. What’s worse, many say, is being ostracized by friends and neighbors who fear the dreaded disease.
Jacques Grosset Interview
Since the beginning of my professional life I have been involved in research to improve the control of tuberculosis, mainly by improving treatment of tuberculosis and preventing the development of drug resistance.
An Interview with Susan Dorman of JHU
Susan Dorman serves on the faculty at Johns Hopkins University in TB Research is also the Medical Director of the Baltimore City TB Clinic. This interview was filmed at JHU on November 13, 2009.
-
You are currently browsing the archives for the Video category.
-
Toppix TB News- Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. 8 Sep 2010
- Global Fund needs U.S. support 8 Sep 2010
- New park memorializes ORC 7 Sep 2010
- Experimental TB test called fast, accurate 7 Sep 2010
- People with diabetes up to 2-3 times higher risk of TB 7 Sep 2010
